Evotec AG Global drug discovery and development company Evotec AG celebrated the opening of its U.S. headquarters and expanded facility in Princeton, NJ.

Werner Lanthaler, chief executive officer of Evotec AG and Ryan Brady, the company’s executive vice president business development and head of U.S. operations were joined by Michele Brown, president and chief executive officer of Choose New Jersey, Inc. and Debbie Hart, president and chief executive officer of BioNJ, to cut the ribbon for the new U.S. headquarters.

“Princeton is an ideal location for our U.S. headquarters based on its proximity to many of the world’s leading biopharmaceutical and Pharma companies and universities, as well as its experienced talent pool that has knowledge and expertise in drug discovery,” said Dr. Lanthaler. “Our Princeton location puts us in easy reach of many our alliance and development partners and gives us the opportunity to cultivate new partnerships in the U.S.”

The company currently has more than 1,200 employees worldwide in its headquarters in Hamburg, Germany and in additional operating sites in Abingdon and Manchester, UK; Göttingen and Munich, Germany; Toulouse, France; and in the U.S. in Branford, CT and Watertown, MA.

Evotec established its Princeton office in 2015 and currently employs a team of more than 20 employees. The 20,000-square-foot expanded facility accommodates additional laboratory and office space for its growing operations in New Jersey.